Avastin to Remain Leader in the Colorectal Cancer Drugs
Roche’s anti-angiogenesis drug Avastin (bevacizumab) has held a dominant position in the CRC market for many years...
Stay updated with breaking news from Analyzing Trends. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Roche’s anti-angiogenesis drug Avastin (bevacizumab) has held a dominant position in the CRC market for many years...
LONDON, July 14, 2022 (GLOBE NEWSWIRE) -- The "Colorectal Cancer – Global Drug Forecast and Market Analysis to 2028" market research report offered by
ALLENDALE — An annual report from Grand Valley State University analyzing health care trends in West Michigan was released Friday, Jan. 8.The report, "Health Check 2021: Analyzing Trends in West Michigan," is the 12th annual report from GVSU compiling data from Kent, Ottawa, Muskegon and Allegan counties, referred to as KOMA in the report.Much of the trend data in this year’s report comes from 2018, with some 2019 data available in certain areas and limited 2020 data used in